DE69816124D1 - Pharmazeutische zusammensetzungen enthaltend zafirlukast - Google Patents

Pharmazeutische zusammensetzungen enthaltend zafirlukast

Info

Publication number
DE69816124D1
DE69816124D1 DE69816124T DE69816124T DE69816124D1 DE 69816124 D1 DE69816124 D1 DE 69816124D1 DE 69816124 T DE69816124 T DE 69816124T DE 69816124 T DE69816124 T DE 69816124T DE 69816124 D1 DE69816124 D1 DE 69816124D1
Authority
DE
Germany
Prior art keywords
pharmaceutical compositions
compositions containing
zafirlukast
containing zafirlukast
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69816124T
Other languages
English (en)
Other versions
DE69816124T2 (de
Inventor
Jane Corvari
Richard Creekmore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca UK Ltd
Original Assignee
AstraZeneca UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca UK Ltd filed Critical AstraZeneca UK Ltd
Publication of DE69816124D1 publication Critical patent/DE69816124D1/de
Application granted granted Critical
Publication of DE69816124T2 publication Critical patent/DE69816124T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
DE69816124T 1997-12-18 1998-12-15 Pharmazeutische zusammensetzungen enthaltend zafirlukast Expired - Fee Related DE69816124T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9726735.5A GB9726735D0 (en) 1997-12-18 1997-12-18 Pharmaceutical compositions
GB9726735 1997-12-18
PCT/GB1998/003765 WO1999032082A2 (en) 1997-12-18 1998-12-15 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
DE69816124D1 true DE69816124D1 (de) 2003-08-07
DE69816124T2 DE69816124T2 (de) 2004-05-06

Family

ID=10823809

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69816124T Expired - Fee Related DE69816124T2 (de) 1997-12-18 1998-12-15 Pharmazeutische zusammensetzungen enthaltend zafirlukast

Country Status (30)

Country Link
US (1) US6399104B1 (de)
EP (1) EP1041966B1 (de)
JP (1) JP2001526206A (de)
KR (1) KR20010033206A (de)
CN (1) CN1282244A (de)
AR (1) AR017884A1 (de)
AT (1) ATE243999T1 (de)
AU (1) AU744326C (de)
BR (1) BR9813666A (de)
CA (1) CA2313163A1 (de)
DE (1) DE69816124T2 (de)
DK (1) DK1041966T3 (de)
EE (1) EE04260B1 (de)
ES (1) ES2202915T3 (de)
GB (1) GB9726735D0 (de)
HU (1) HUP0004669A3 (de)
ID (1) ID25857A (de)
IL (1) IL136501A0 (de)
IN (1) IN191311B (de)
MY (1) MY133096A (de)
NO (1) NO20003141D0 (de)
NZ (1) NZ504566A (de)
PL (1) PL341736A1 (de)
PT (1) PT1041966E (de)
RU (1) RU2205006C2 (de)
SK (1) SK9402000A3 (de)
TR (1) TR200001713T2 (de)
UA (1) UA62991C2 (de)
WO (1) WO1999032082A2 (de)
ZA (1) ZA9811532B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO319624B1 (no) 2003-09-15 2005-09-05 Trouw Internat Bv Fiskefôr for laksefisk i ferskvann og anvendelse av slikt fôr.
US20050113410A1 (en) * 2003-11-03 2005-05-26 Mark Tawa Pharmaceutical salts of zafirlukast
DE102006006532B4 (de) * 2006-02-10 2007-11-08 Biogenerics Pharma Gmbh Pharmazeutische Zubereitung
CN101516339B (zh) * 2006-08-16 2012-06-13 诺瓦提斯公司 制备高度结晶的治疗化合物的固体分散体的方法
CA2684655A1 (en) * 2007-03-26 2008-10-02 Teikoku Seiyaku Co., Ltd. Oral pharmaceutical preparation for colon-specific delivery
US20090012146A1 (en) * 2007-07-02 2009-01-08 Giridhar Reddy Buggana Solubility-enhanced pharmaceutical compositions comprising zafirlukast
EP3585809A4 (de) 2017-01-30 2021-02-24 Western New England University Thiolisomerasen-inhibitoren und verwendung davon
CN107714694A (zh) * 2017-11-01 2018-02-23 天津国际生物医药联合研究院 扎鲁司特在抗结核分枝杆菌感染中的应用
EP4340828A1 (de) 2021-05-19 2024-03-27 Quercis Pharma AG Quercetinhaltige zusammensetzungen zur verwendung bei der behandlung von amyotropher lateralsklerose
WO2023214391A1 (en) 2022-05-06 2023-11-09 Quercis Pharma AG Method for treating cancers and neurological diseases using quercetin-containing compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607294D0 (en) * 1985-04-17 1986-04-30 Ici America Inc Heterocyclic amide derivatives
IL100091A (en) * 1990-12-12 1998-08-16 Zeneca Ltd Pharmaceutical preparations containing the physical form of [4] 5) Cyclopentyloxycarbyl (amino 1 methyl indole 3 methyl methyl [3 methoxybenzoyl [2 methylbenzole)
GB9027018D0 (en) * 1990-12-12 1991-01-30 Ici Plc Heterocyclic compounds

Also Published As

Publication number Publication date
CA2313163A1 (en) 1999-07-01
HUP0004669A3 (en) 2005-03-29
CN1282244A (zh) 2001-01-31
IL136501A0 (en) 2001-06-14
KR20010033206A (ko) 2001-04-25
AU1571199A (en) 1999-07-12
TR200001713T2 (tr) 2000-10-23
WO1999032082A3 (en) 1999-09-16
IN191311B (de) 2003-11-22
GB9726735D0 (en) 1998-02-18
AR017884A1 (es) 2001-10-24
ATE243999T1 (de) 2003-07-15
PT1041966E (pt) 2003-11-28
NO20003141L (no) 2000-06-16
PL341736A1 (en) 2001-05-07
EP1041966B1 (de) 2003-07-02
DE69816124T2 (de) 2004-05-06
ES2202915T3 (es) 2004-04-01
WO1999032082A2 (en) 1999-07-01
HUP0004669A1 (hu) 2001-08-28
ID25857A (id) 2000-11-09
ZA9811532B (en) 1999-06-18
NO20003141D0 (no) 2000-06-16
NZ504566A (en) 2002-10-25
MY133096A (en) 2007-10-31
AU744326B2 (en) 2002-02-21
RU2205006C2 (ru) 2003-05-27
AU744326C (en) 2002-11-07
JP2001526206A (ja) 2001-12-18
EE200000330A (et) 2001-08-15
EP1041966A2 (de) 2000-10-11
EE04260B1 (et) 2004-04-15
US6399104B1 (en) 2002-06-04
UA62991C2 (en) 2004-01-15
BR9813666A (pt) 2000-10-10
DK1041966T3 (da) 2003-10-06
SK9402000A3 (en) 2001-01-18

Similar Documents

Publication Publication Date Title
DE69924999D1 (de) Lipasehemmer enthaltende pharmazeutische zusammensetzungen
DK1001813T3 (da) Farmaceutiske formuleringer indeholdende voriconazol
DE69726015D1 (de) Pharmazeutische zusammensetzung enthaltend koenzym q-10
ATE230611T1 (de) Pharmazeutische zusammensetzungen mit plasmaproteinen
ATE222751T1 (de) Pharmazeutische aerosolzusammensetzung
CY2005007I2 (el) Φαρμακευτικες συνθεσεις που περιεχουν δαριφενακινη
ID22891A (id) Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
EE03852B1 (et) Bensofuraani derivaate sisaldav tahke farmatseutiline kompositsioon
DE69900561T2 (de) Pharmazeutische Zusammensetzungen enthaltend Mupirocin
DE59801987D1 (de) Pharmazeutische zusammensetzung enthaltend peptichemio
DE69614407D1 (de) Pharmazeutische zusammensetzungen
DE69830154D1 (de) Pharmazeutische zusammensetzungen
EE9800400A (et) Diklofenaaki sisaldavad farmatseutilised kompositsioonid
ATE243999T1 (de) Pharmazeutische zusammensetzungen enthaltend zafirlukast
DE69708130D1 (de) A-oxo-butansäuren enthaltende pharmazeutische zusammensetzung
MA26531A1 (fr) Composition pharmaceutique
EE9900206A (et) N-sulfonüülindoliiniderivaate sisaldavad farmatseutilised kompositsioonid
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
DE69706833T2 (de) Pharmazeutische zusammensetzungen enthaltend famciclovir monohydrat
ID23531A (id) Komposisi farmasi
BR1100755A (pt) composição farmacêutica
ID21180A (id) Senyawa-senyawa farmasi
IT1284509B1 (it) Composizioni farmaceutiche effervescenti contenenti metansolfoanilidi
IT1288113B1 (it) Composizioni farmaceutiche effervescenti contenenti sobrerolo

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee